The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, the reported perforation was likely related to procedural conditions.Perforation is listed in the mitraclip instructions for use (ifu) as a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.
|
This is being filed to report the atrial septal defect requiring intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 3.One clip was implanted, reducing mr to 1.After removal of the steerable guide catheter (sgc), patent foramen ovale was noted with right left and left right shunt realized, and was then treated with an asd occluder.There was no clinically significant delay in the procedure and no adverse patient sequela.No additional information was provided.
|